IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Diet and Lifestyle in Diabetes, A Kerala Perspective

Review Article, Volume 09 Issue 3 – July to September 2016

Authors

Dr Rajeev Jayadevan, MD (Vellore), DNB, MRCP, American Board Certification in Medicine and Gastroenterology, Senior Consultant Gastroenterologist and Deputy Medical Director, Sunrise Group of Hospitals


Abstract

When prescribing diet and lifestyle to diabetic patients, cultural and family preferences should be considered for better compliance. In Kerala, the quantity of rice consumed per meal needs to be curbed. Whole grains should replace refined grains. Repeat servings must be discouraged to ensure portion control. Fruit juices, sweets and sweetened beverages need to be limited or avoided, and healthy snacks promoted. Trans-fats are to be avoided, and the overall use of oil, no matter how healthy it is claimed to be, must be minimised. Saturated fats raise LDL levels and are considered unhealthy at this time. Structured diet and exercise programs work better than plain advice. At least 2.5 hours of exercise is recommended per week, and has multiple benefits. Reducing work-related stress levels, and getting adequate sleep must be given due importance while recommending lifestyle modifications.


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician